Failure of Bamlanivimab with Selection of E484K Mutation in an Allogeneic Stem Cell Transplant Recipient with Nosocomial SARS-CoV-2 Infection.
ANTIVIRAL THERAPY(2024)
Key words
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),bamlanivimab,mutation,immune escape,allogeneic stem cell transplant recipient
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined